BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9290548)

  • 1. Perioperative management of colon cancer under Medicare risk programs.
    Retchin SM; Penberthy L; Desch C; Brown R; Jerome-D'Emilia B; Clement D
    Arch Intern Med; 1997 Sep; 157(16):1878-84. PubMed ID: 9290548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of utilization for the Minnesota senior health options program.
    Kane RL; Homyak P; Bershadsky B; Flood S; Zhang H
    J Am Geriatr Soc; 2004 Dec; 52(12):2039-44. PubMed ID: 15571539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How the elderly fare in HMOs: outcomes from the Medicare competition demonstrations.
    Retchin SM; Clement DG; Rossiter LF; Brown B; Brown R; Nelson L
    Health Serv Res; 1992 Dec; 27(5):651-69. PubMed ID: 1464538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of Medicare fee-for-service and a group-model HMO in the inpatient management and long-term survival of elderly individuals with syncope.
    Getchell WS; Larsen GC; Morris CD; McAnulty JH
    Am J Manag Care; 2000 Oct; 6(10):1089-98. PubMed ID: 11184665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospice use in Medicare managed care and fee-for-service systems.
    Virnig BA; Fisher ES; McBean AM; Kind S
    Am J Manag Care; 2001 Aug; 7(8):777-86. PubMed ID: 11519237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Medicare health care systems on women with breast and cervical cancer.
    Kirsner RS; Ma F; Fleming L; Trapido E; Duncan R; Federman DG; Wilkinson JD
    Obstet Gynecol; 2005 Jun; 105(6):1381-8. PubMed ID: 15932833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of functional outcomes after hip fracture in group/staff HMOs and fee-for-service systems.
    Coleman EA; Kramer AM; Kowalsky JC; Eckhoff D; Lin M; Hester EJ; Morgenstern N; Steiner JF
    Eff Clin Pract; 2000; 3(5):229-39. PubMed ID: 11185328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of Medicare health care delivery systems with stage at diagnosis and survival for patients with melanoma.
    Kirsner RS; Wilkinson JD; Ma F; Pacheco H; Federman DG
    Arch Dermatol; 2005 Jun; 141(6):753-7. PubMed ID: 15967922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of HMOs on fee-for-service health care expenditures: evidence from Medicare revisited.
    Batata A
    J Health Econ; 2004 Sep; 23(5):951-63. PubMed ID: 15353188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do Medicare HMOs still reduce health services use after controlling for selection bias?
    Mello MM; Stearns SC; Norton EC
    Health Econ; 2002 Jun; 11(4):323-40. PubMed ID: 12007164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer treatment and ten-year survival among group/staff HMO and fee-for-service Medicare patients.
    Potosky AL; Merrill RM; Riley GF; Taplin SH; Barlow W; Fireman BH; Lubitz JD
    Health Serv Res; 1999 Jun; 34(2):525-46. PubMed ID: 10357289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes and resource utilization associated with laparoscopic and open colectomy using a large national database.
    Delaney CP; Chang E; Senagore AJ; Broder M
    Ann Surg; 2008 May; 247(5):819-24. PubMed ID: 18438119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of medicare health maintenance organizations on hospitalization rates for ambulatory care-sensitive conditions.
    Zeng F; O'Leary JF; Sloss EM; Lopez MS; Dhanani N; Melnick G
    Med Care; 2006 Oct; 44(10):900-7. PubMed ID: 17001260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing mortality and time until death for medicare HMO and FFS beneficiaries.
    Maciejewski ML; Dowd B; Call KT; Feldman R
    Health Serv Res; 2001 Feb; 35(6):1245-65. PubMed ID: 11221818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
    Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB
    Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare Advantage and the impact of Medicare HMOs on inpatient utilization.
    Minott J
    Find Brief; 2007 Oct; 10(9):1-3. PubMed ID: 18019951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
    Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of medicare health care delivery systems on survival for patients with breast and colorectal cancer.
    Kirsner RS; Ma F; Fleming L; Federman DG; Trapido E; Duncan R; Wilkinson JD
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):769-73. PubMed ID: 16614122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
    Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
    Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicare HMOs: who joins and who leaves?
    Virnig BA; Morgan RO; DeVito CA; Persily NA
    Am J Manag Care; 1998 Apr; 4(4):511-8. PubMed ID: 10179910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.